Summary:
- A moving average of Short volume ratio is at a recent 2 week high. A high short volume ratio indicate selling presures.
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Stock news
PHILADELPHIA, PA / ACCESSWIRE / December 19, 2020 / Kaskela Law LLC announces that it is investigating Summit Therapeutics Inc.
Summit Therapeutics (SMMT) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Summit Therapeutics Inc. (‘Summit,’ the ‘Company,’ or the ‘Group’)Summit Therapeutics Appoints Dr. Mahkam (“Maky”) Zanganeh as Chief Operating OfficerCambridge, MA, November 23, 2020 – Summit Therapeutics Inc. (NASDAQ: SMMT) announces that Dr. Mahkam “Maky” Zanganeh, DDS, MBA, has been appointed as Chief Operating Officer, effective immediately. Dr. Zanganeh is currently a member of the Company’s Board of Directors, having been appointed on November 11, 2020. “Maky’s strategic leadership and o...
Summit Therapeutics Inc. (‘Summit’, the ‘Company’ or the ‘Group’)Summit Therapeutics Reports Financial Results and Operational Progress for the Third Quarter and Nine Months Ended September 30, 2020Cambridge, MA, November 16, 2020 \- Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on its operational progress for the third quarter and nine months ended September 30, 2020.Ridinilazole for C. difficile Infection (‘CDI’) 1. As of November 15, 2020...
Summit Therapeutics Inc. (“Summit” or the “Company”)Summit Announces Closing of Private Placement of $50 MillionCambridge, MA, November 6, 2020 – Summit (NASDAQ: SMMT) today announces that it has closed its previously announced private placement for a fundraising of $50 million (the “Fundraising”) through the issuance and sale of shares of common stock to the Company’s Chief Executive Officer and Executive Chairman, Robert W. Duggan and to two additional investors. Summit placed 14,071,856 new...
Here are 5 stocks added to the Zacks Rank 5 (Strong Sell) List today
Summit Therapeutics Inc.(“Summit” or the “Company”)Summit Announces Agreement For a Fundraising of approximately $50 MillionCambridge, MA, October 2, 2020 – Summit (NASDAQ: SMMT) today announces that it has entered into a binding agreement with the Company’s Chief Executive Officer and Executive Chairman, Robert W. Duggan, for a fundraising of approximately $50 million (the “Fundraising”) through the issuance and sale in a private placement of shares of common stock to Mr. Duggan. The transacti...
Summit Therapeutics Inc. (‘Summit’, the ‘Company’ or the ‘Group’)Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2020Cambridge, MA, September 29, 2020 \- Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on its operational progress for the second quarter and six months ended June 30, 2020.Ridinilazole for C. difficile Infection (‘CDI’) 1. Summit published data from its P...